ConductScience.org, home

Trial · NCT03492281

Outcomes15

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange From Baseline (CFB) at Week 12 in the Average Number of Micturitions Per 24 Hours in All Overactive Bladder (OAB) ParticipantsBaseline (BL); Week 12FAS: all randomized participants who took at least 1 dose of double-blind study treatment and had at least 1 evaluable CFB measurement. Only participants with evaluable data were analyzed.micturitions per 24 hoursLEAST_SQUARES_MEAN
PRIMARYCFB at Week 12 in the Average Number of Urge Urinary Incontinence (UUI) Episodes Per 24 Hours in OAB Wet ParticipantsBaseline; Week 12
FAS-I: all randomized OAB Wet participants who took at least 1 dose of double-blind study treatment and had at least 1 evaluable CFB measurement. Only those participants with evaluable data were analyzed.
UUI episodes per 24 hoursLEAST_SQUARES_MEAN
SECONDARYCFB at Week 12 in the Average Number of Urgency Episodes Over 24 Hours in All OAB ParticipantsBaseline; Week 12FAS. Only participants with evaluable data were analyzed.urgency episodes over 24 hoursLEAST_SQUARES_MEAN
SECONDARYPercentage of OAB Wet Participants With at Least a 75% Reduction From Baseline in UUI Episodes Per 24 Hours at Week 12Baseline; Week 12FAS-I. The multiple imputation method was used for missing values.percentage of participantsNUMBER
SECONDARYPercentage of OAB Wet Participants With a 100% Reduction From Baseline in UUI Episodes Per 24 Hours at Week 12Baseline; Week 12FAS-I. The multiple imputation method was used for missing values.percentage of participantsNUMBER
SECONDARYPercentage of All OAB Participants With at Least a 50% Reduction From Baseline in Urgency Episodes Per 24 Hours at Week 12Baseline; Week 12FAS. The multiple imputation method was used for missing values.percentage of participantsNUMBER
SECONDARYCFB at Week 12 in the Average Number of Total Incontinence Episodes Over 24 Hours in OAB Wet ParticipantsBaseline; Week 12FAS-I. Only participants with evaluable data were analyzed.total incontinence episodes over 24 hrLEAST_SQUARES_MEAN
SECONDARYCFB at Week 12 in the Coping Score From the Overactive Bladder Questionnaire Long Form (OAB-q LF, 1-week Recall) in All OAB ParticipantsBaseline; Week 12
FAS. Only participants with evaluable data were analyzed. If \< 50% of items were available, the subscore was regarded as missing; however, if ≥ 50% of items were available, the subscore included missing items imputed as the average of the remaining non-missing items for the subscore.
units on a scaleLEAST_SQUARES_MEAN
SECONDARYCFB at Week 12 in the Average Volume Voided Per Micturition in All OAB ParticipantsBaseline; Week 12FAS. Only participants with evaluable data were analyzed.mL per micturitionLEAST_SQUARES_MEAN
SECONDARYCFB at Week 12 in the Health-related Quality of Life (HRQL) Total Score From the OAB-q LF (1-week Recall) in All OAB ParticipantsBaseline; Week 12
FAS. Only participants with evaluable data were analyzed. If \< 50% of items were available, the subscore was regarded as missing; however, if ≥ 50% of items were available, the subscore included missing items imputed as the average of the remaining non-missing items for the subscore.
units on a scaleLEAST_SQUARES_MEAN
SECONDARYCFB at Week 12 in the Symptom Bother Score From the OAB-q LF (1-week Recall) in All OAB ParticipantsBaseline; Week 12
FAS. Only participants with evaluable data were analyzed. If \< 50% of items were available, the subscore was regarded as missing; however, if ≥ 50% of items were available, the subscore included missing items imputed as the average of the remaining non-missing items for the subscore.
units on a scaleLEAST_SQUARES_MEAN
SECONDARYPercentage of All OAB Participants With an Average Number of Micturitions < 8 Per 24 Hours at Week 12Week 12FAS. Only participants with evaluable data were analyzed.percentage of participantsNUMBER
SECONDARYPercentage of OAB Wet Participants With at Least a 50% Reduction From Baseline in Total Incontinence Episodes Per 24 Hours at Week 12Baseline; Week 12FAS-I. Only participants with evaluable data were analyzed. The multiple imputation method was used for missing values.percentage of participantsNUMBER
SECONDARYCFB at Week 12 in Overall Bladder Symptoms Based on Patient Global Impression of Severity (PGI-Severity) in All OAB ParticipantsBaseline; Week 12FAS. Only participants with evaluable data were analyzed.units on a scaleLEAST_SQUARES_MEAN
SECONDARYCFB at Week 12 in Overall Control Over Bladder Symptoms Based on Patient Global Impression of Control (PGI-Control) in All OAB ParticipantsBaseline; Week 12FAS. Only participants with evaluable data were analyzed.units on a scaleLEAST_SQUARES_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03492281/outcomes